Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Devos

Showing results (201-210 of 220) with videos related to

Pageof 22
Sort By:
Journal of Parkinson'S Disease|April 5, 2024
Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials InitiativeRichard K Wyse, Tom Isaacs, Roger A Barker, et al.
Journal of Parkinson'S Disease|December 13, 2021
Personality Related to Quality-of-Life Improvement After Deep Brain Stimulation in Parkinson's Disease (PSYCHO-STIM II)Mathilde Boussac, Christophe Arbus, Helene Klinger, et al.
Journal of Parkinson'S Disease|February 20, 2025
Therapeutic modalities of deferiprone in Parkinson's disease: SKY and EMBARK studiesDavid Devos, Olivier Rascol, Wassilios G Meissner, et al.
Antioxidants & Redox Signaling|November 21, 2013
Targeting chelatable iron as a therapeutic modality in Parkinson's diseaseDavid Devos, Caroline Moreau, Jean Christophe Devedjian, et al.
Journal of Parkinson'S Disease|May 23, 2022
Heterogeneity of PD-MCI in Candidates to Subthalamic Deep Brain Stimulation: Associated Cortical and Subcortical ModificationsQuentin Devignes, Sami Daoudi, Romain Viard, et al.
Clinical Parkinsonism & Related Disorders|February 20, 2026
Effects of deep brain stimulation on non motor fluctuations in Parkinson's disease (assessed with the NMF severity scale)Christian Matta, Camille Comet, Corentin Gaillard, et al.
NPJ Parkinson'S Disease|November 21, 2025
Author Correction: Classification of GBA1 variants and their impact on Parkinson's disease: an in silico score analysisAymeric Lanore, Christelle Tesson, Aymeric Basset, et al.
NPJ Parkinson'S Disease|August 2, 2025
Classification of GBA1 variants and their impact on Parkinson's disease: an in silico score analysisAymeric Lanore, Christelle Tesson, Aymeric Basset, et al.
BMJ Neurology Open|January 21, 2026
Understanding dopaminergic dose reduction following STN-DBS: mediation analysisAymeric Lanore, Marion Houot, Aymeric Basset, et al.
Biomolecules|July 27, 2022
Keeping Cell Death Alive: An Introduction into the French Cell Death Research NetworkGabriel Ichim, Benjamin Gibert, Sahil Adriouch, et al.
Pageof 22

Showing results (201-210 of 220) with videos related to

Sort By:
Pageof 22
Journal of Parkinson'S Disease|April 5, 2024
Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials InitiativeRichard K Wyse, Tom Isaacs, Roger A Barker, et al.
Journal of Parkinson'S Disease|December 13, 2021
Personality Related to Quality-of-Life Improvement After Deep Brain Stimulation in Parkinson's Disease (PSYCHO-STIM II)Mathilde Boussac, Christophe Arbus, Helene Klinger, et al.
Journal of Parkinson'S Disease|February 20, 2025
Therapeutic modalities of deferiprone in Parkinson's disease: SKY and EMBARK studiesDavid Devos, Olivier Rascol, Wassilios G Meissner, et al.
Antioxidants & Redox Signaling|November 21, 2013
Targeting chelatable iron as a therapeutic modality in Parkinson's diseaseDavid Devos, Caroline Moreau, Jean Christophe Devedjian, et al.
Journal of Parkinson'S Disease|May 23, 2022
Heterogeneity of PD-MCI in Candidates to Subthalamic Deep Brain Stimulation: Associated Cortical and Subcortical ModificationsQuentin Devignes, Sami Daoudi, Romain Viard, et al.
Clinical Parkinsonism & Related Disorders|February 20, 2026
Effects of deep brain stimulation on non motor fluctuations in Parkinson's disease (assessed with the NMF severity scale)Christian Matta, Camille Comet, Corentin Gaillard, et al.
NPJ Parkinson'S Disease|November 21, 2025
Author Correction: Classification of GBA1 variants and their impact on Parkinson's disease: an in silico score analysisAymeric Lanore, Christelle Tesson, Aymeric Basset, et al.
NPJ Parkinson'S Disease|August 2, 2025
Classification of GBA1 variants and their impact on Parkinson's disease: an in silico score analysisAymeric Lanore, Christelle Tesson, Aymeric Basset, et al.
BMJ Neurology Open|January 21, 2026
Understanding dopaminergic dose reduction following STN-DBS: mediation analysisAymeric Lanore, Marion Houot, Aymeric Basset, et al.
Biomolecules|July 27, 2022
Keeping Cell Death Alive: An Introduction into the French Cell Death Research NetworkGabriel Ichim, Benjamin Gibert, Sahil Adriouch, et al.
Pageof 22